These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 28329246)
21. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma. Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575 [TBL] [Abstract][Full Text] [Related]
22. Prediction of prognosis after trimodal therapy in patients with locally advanced squamous cell carcinoma of the oesophagus. Stahl M; Lehmann N; Walz MK; Stuschke M; Wilke H Eur J Cancer; 2012 Nov; 48(16):2977-82. PubMed ID: 22503151 [TBL] [Abstract][Full Text] [Related]
23. Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer. Lim SH; Hong M; Ahn S; Choi YL; Kim KM; Oh D; Ahn YC; Jung SH; Ahn MJ; Park K; Zo JI; Shim YM; Sun JM Eur J Cancer; 2016 Jan; 52():1-9. PubMed ID: 26623522 [TBL] [Abstract][Full Text] [Related]
24. Prognostic analysis of salvage esophagectomy after definitive chemoradiotherapy for esophageal squamous cell carcinoma: the importance of lymphadenectomy. Wang S; Tachimori Y; Hokamura N; Igaki H; Nakazato H; Kishino T J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1805-11. PubMed ID: 24521950 [TBL] [Abstract][Full Text] [Related]
25. Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision. Lee JH; Jang HS; Kim JG; Cho HM; Shim BY; Oh ST; Yoon SC; Kim YS; Choi BO; Kim SH Ann Surg Oncol; 2012 Apr; 19(4):1213-21. PubMed ID: 21935746 [TBL] [Abstract][Full Text] [Related]
26. Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy. Kurokawa T; Hamai Y; Emi M; Ibuki Y; Yoshikawa T; Ohsawa M; Hirohata R; Okada M Anticancer Res; 2020 Aug; 40(8):4387-4394. PubMed ID: 32727767 [TBL] [Abstract][Full Text] [Related]
27. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy]. Ma R; Zhang H; Zou L; Qu Y Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610 [TBL] [Abstract][Full Text] [Related]
28. Prognosis of Patients With Pathologic T0 N+ Esophageal Squamous Cell Carcinoma After Chemoradiotherapy and Surgical Resection: Results From a Nationwide Study. Chao YK; Chen HS; Wang BY; Hsu PK; Liu CC; Wu SC Ann Thorac Surg; 2016 May; 101(5):1897-902. PubMed ID: 26912307 [TBL] [Abstract][Full Text] [Related]
29. Risk factors of early recurrence within 6 months after esophagectomy following neoadjuvant chemotherapy for resectable advanced esophageal squamous cell carcinoma. Yoshida N; Baba Y; Shigaki H; Harada K; Iwatsuki M; Sakamoto Y; Miyamoto Y; Kurashige J; Kosumi K; Tokunaga R; Watanabe M; Baba H Int J Clin Oncol; 2016 Dec; 21(6):1071-1078. PubMed ID: 27255393 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic strategy for the treatment of postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy of radiotherapy. Maruyama K; Motoyama S; Anbai A; Usami S; Sato Y; Shibuya K; Yoshino K; Nakatsu T; Minamiya Y; Ogawa JI Dis Esophagus; 2011 Apr; 24(3):166-71. PubMed ID: 20946135 [TBL] [Abstract][Full Text] [Related]
31. Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy. Kiyozumi Y; Yoshida N; Ishimoto T; Yagi T; Koga Y; Uchihara T; Sawayama H; Hiyoshi Y; Iwatsuki M; Baba Y; Miyamoto Y; Watanabe M; Matsuyama T; Oya N; Baba H World J Surg; 2018 Sep; 42(9):2887-2893. PubMed ID: 29423738 [TBL] [Abstract][Full Text] [Related]
32. Extramural perineural invasion in pT3 and pT4 rectal adenocarcinoma as prognostic factor after preoperative chemoradiotherapy. Lino-Silva LS; Salcedo-Hernández RA; España-Ferrufino A; Ruiz-García EB; Ruiz-Campos M; León-Takahashi AM; Meneses-García A Hum Pathol; 2017 Jul; 65():107-112. PubMed ID: 28526604 [TBL] [Abstract][Full Text] [Related]
33. The prognostic value of circumferential resection margin in esophageal squamous cell carcinoma after concurrent chemoradiation therapy and surgery. Liu CY; Wang BY; Lee MY; Tsai YC; Liu CC; Shih CH J Chin Med Assoc; 2013 Oct; 76(10):570-5. PubMed ID: 23938149 [TBL] [Abstract][Full Text] [Related]
34. Pattern of recurrence and prognostic factors in patients with pT1-3 N0 esophageal squamous cell carcinoma after surgery: analysis of a single center experience. Lin G; Liu H; Li J J Cardiothorac Surg; 2019 Mar; 14(1):58. PubMed ID: 30866983 [TBL] [Abstract][Full Text] [Related]
35. Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma. Kang CH; Hwang Y; Lee HJ; Park IK; Kim YT Ann Thorac Surg; 2016 Oct; 102(4):1074-80. PubMed ID: 27302078 [TBL] [Abstract][Full Text] [Related]
37. Postoperative chemoradiotherapy improves survival in patients with stage II-III esophageal squamous cell carcinoma: An analysis of clinical outcomes. Zou B; Pang J; Liu Y; Xu Y; Li L; Zhou L; Zhu J; Huang M; Wang J; Ren L; Gong Y; Lu Y; Chen L; Peng F Thorac Cancer; 2016 Sep; 7(5):515-521. PubMed ID: 27766781 [TBL] [Abstract][Full Text] [Related]
38. Lymphovascular Invasion as the Major Prognostic Factor in Node-Negative Esophageal Cancer After Primary Esophagectomy. Hsu CP; Chuang CY; Hsu PK; Chien LI; Lin CH; Yeh YC; Hsu HS; Wu YC J Gastrointest Surg; 2020 Jul; 24(7):1459-1468. PubMed ID: 31273552 [TBL] [Abstract][Full Text] [Related]
39. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma]. Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998 [TBL] [Abstract][Full Text] [Related]
40. Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone. Robb WB; Messager M; Dahan L; Mornex F; Maillard E; D'Journo XB; Triboulet JP; Bedenne L; Seitz JF; Mariette C; ; ; ; ; Br J Surg; 2016 Jan; 103(1):117-25. PubMed ID: 26511668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]